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ABSTRACT  Monoclonal antibodies against the highly conserved  ubiquitous calcium-binding protein, 
calmodulin  (CAM),  were  produced  by immunization  of  mouse  primary spleen  cell  cultures.  Disso- 
ciated  spleen  cells  were cultured  for 5 d  in  the  presence  of  mixed thymocyte culture  conditioned 
media (TCM) and purified bovine testes CaM (50 ng-1  mg). Following immunization, cells were fused 
with  mouse  myeloma  cells  (SP2/0, Ag 8.653) and  cultured  for  2-3  wk  before  initial  screening  for 
antibody. In five independent  immunizations  there was a range of 25-44% of the initial polyclonal 
cultures which produced antibodies reacting with purified CaM as determined by immunoassay.  80% 
of  the  cloned  hybridoma  produced  IgM  immunoglobulins  while  the  remaining  clones  were  IgG 
producers.  This  ratio was changed  to 50% IgM and 50% IgG by subsequent extension of the in vitro 
immunization  periods  and  reduced  amounts  of  antigen  and  extended  in  vitro culturing.  In  vitro 
immunization introduces a new dimension to monoclonal antibody production where limited antigen 
or poorly antigenic proteins are of interest. The  monoclonal  antibodies produced  in this study have 
enabled us to to selectively localize CaM in association  with distinct subcellular structures, mitochon- 
dria, stress fibers, centrioles, and the mitotic spindle. 
Production of antibodies against the calcium-binding protein, 
calmodulin (CAM), by conventional animal immunization reg- 
imens has required either large quantities (milligram range) of 
native CaM (1, 2) or chemical modification of the protein to 
increase  its  antigenicity  (3,  4).  These  procedures  result  in 
antisera which consist of a  pool of polyclonal antibodies that 
collectively recognize multiple antigenic determinants  on the 
immunogen.  In contrast, monoclonal antibodies represent in- 
dividual,  homogeneous classes of immunoglobulins  which,  if 
properly selected, may recognize discrete antigenic configura- 
tions of a  given immunogen.  Calmodulin  has been shown to 
be capable of binding to many intracellular sites, presumably 
to proteins that are Ca2÷-calmodulin regulated (5). Depending 
upon which protein and where in the cell it is bound, different 
antigenic  sites or segments of one  antigenic site are exposed 
and accessible for antibody binding. Monoclonal antibodies to 
calmodulin (CAM) would permit the independent  monitoring 
of intracellular  CaM bound in different spatial or conforma- 
tional states. Such differential localization would provide val- 
uable information in further delineating the cellular function 
of CaM during various metabolic states. 
In  vivo  immunization  for  the  production  of monoclonal 
antibodies against preselected antigens has become a  routine 
laboratory procedure.  However, relatively large quantities  of 
the antigen are still required for injection into the host animal 
(6),  and each animal must be screened as a  producer.  Alter- 
natively, spleen cells have been activated with mitogen (7) and 
immunized  with  sheep erythrocytes  (8)  in vitro,  resulting  in 
specific monoclonal antibody production.  In vitro immuniza- 
tion of spleen cell cultures permits a reduction in the amount 
of antigen required and enables enhanced recovery of specific 
antigen-activated  clones (9,  10,  11,  12).  In the present study, 
we have used an in vitro immunization protocol with a soluble 
protein antigen  (bovine testes CaM)  followed by fusion with 
mouse myeloma cells (SP2/0, Ag 8.653) to produce monoclonal 
antibodies.  This technique  was first reported  by Luben  and 
Mohler (9), Mishell and Dutton (11), and Click (12) and is the 
subject of recent review (13).  The procedure utilizes a murine 
allogenic thymocyte culture to generate lymphokines that stim- 
ulate lymphocytes in the presence of antigen to promote anti- 
body production.  A preliminary report of this work has been 
presented (14). 
MATERIALS  AND  METHODS 
Preparation  of  Thymocyte-Conditioned  Media:  10  (5 
BALB/c, 5 C-57) mouse thymuses were surgically removed from 2-4-week-old 
animals and passed through a 50-mesh stainless steel screen. Thymus cells (4 × 
106 ceUs/ml) were cultured  in  Dulbecco's modified Eagle's medium (DME) 
(Gibco Laboratories, Grand Island Biological  Co., Grand Island, NY) containing 
4,500 mg glucose/l, 2  mM  glutamine, 5  x  10  -~  M-mercaptoethanol,  l0 mM 
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pyruvate in 18 mM HEPES buffer with 12% type 100 rabbit serum (Quadroma, 
San  Marcos,  CA).  Ceils  were  cultured  for  48  h  at  37°C  in  5%  CO2.  The 
thymocyte-conditioned medium (TCM)  was then harvested by centrifugation 
(500 g for 5 min to pellet the thymus ceils) and the supernatant (TCM) stored at 
-70°C. 
Isolation  and  Immunization  of  Spleen Cells:  Individual 
spleens from nonimmunized BALB/c mice were surgically removed and washed 
three times in Hanks' balanced salt solution, pH 7.4. Spleen cells were mechani- 
cally  dissociated as mentioned above. Individual  in vitro immunizations  consisted 
of the dropwise addition of the appropriate amount of antigen (callodulin 1 nag, 
500 #g, 200 #g, 100 #g, 500 rig, 200 ng, 50 ng, and 0 ng) directly to a 60-mm tissue 
culture dish containing 10 ml of serum-free DME and incubated at 22°C for 15 
min. Following this initial incubation the  10 ml of antigen-exposed cells were 
transferred to a T-75 tissue culture flask containing an additional 10 ml of DME 
supplemented with 10 ml of TCM (SDME) and final serum concentration of 5%. 
The 30 ml of SDME with 5% rabbit serum containing 10  a spleen cells  and antigen 
were  cultured  for  4-5  d  at  37°C,  5%  CO2.  Following this  5  day  in  vitro 
immunization period, the individual cultures were centrifuged (5 min at 500 g) 
and  the  pelleted cells were  mixed with  SP2/0  or  P3  X  63  Ag  8.653  mouse 
myeloma cells at a ratio 2:1 (spleen/myeloma cell) and co-pelleted by centrifu- 
gation. This myeloma and spleen cell mixture was fused in 47%  polyethylene 
glycol  (1,540 mol wt) and 3% dimethylsulfoxide  according to previously  published 
procedures (6). The fused cells were cultured in 80 ml of DME-HT media with 
12% rabbit or fetal calf serum for 24 h. Aminopterin (10  -~ M) was added to the 
media along with a feeder layer of nonimmune spleen cells (15) in 24-well tissue 
culture plates (Linbro) (1 ml/well) for 24  wk before screening was initiated. 
Enzyme  Immunosorbent  Assay:  30  ng  of  bovine  testes  cal- 
modulin in 100 itl of phosphate buffer saline, pH 6.9 was added to each well of 
a 96-well microtiter plate (Dynatecb, Immunlon II) and incubated overnight at 
4°C.  Calmodulin was prepared as described according to  Dedman et al. (1). 
Unbound  calmodulin was removed from the wells by washing 10 times in  10 
mM  sodium  phosphate,  pH  7.4,  0.15  M  NaC1,  0.2%  Triton  X-100  (PBST). 
Nonspecilic sites were then blocked for 1 h at room temperature by the addition 
of 100/zl of PBS with 10 mg/ml bovine serum albumin (Sigma Chemical Co.). 
Wells were then washed 10 times in PBST,  and 50 lzl of cell supernatant was 
added and incubated for 2 h at 37°C. The wells were again washed 10 times in 
PBST. 30 #1 of peroxidase-tagged goat anti-mouse IgG or IgM (1/500 dilution) 
was added and incubated at 37°C for  1 h.  After second antibody incubation, 
wells were washed 10 times in PBST, 200 #1 of substrate,  10 ml of 0.1  M citrate 
buffer pH 4.5,  10 mg of orthophenyldiamine (Sigma Chemical Co.),  4 #1 30% 
H202.  Reaction was allowed to proceed for 30 min and then was blocked with 5 
/d of 1 M  NaF. Optical densities were read on a  Dynascan spectrophotometer 
(Dynatech, Inc.). 
Fluorescence Microscopy:  Swiss 3T3 fibroblasts were grown on 11 
x  22 nun coverslips, fu(ed in 3% formaldehyde (20 rain), lysed in 0.1% Triton X- 
100 (90 s), and stained with primary monoclonal antibodies to purified bovine 
testes calmodulin (14,  16). Lysed ceils were incubated for 1 h in affinity-purified 
antibody (0.1 mg/ml) or a Na2SO,-precipitated fraction of hybridoma superna- 
tant media, washed in PBS,  pH 7.4,  then incubated in fluorescein-conjugated 
goat anti-mouse immunoglobulin (Miles Laboratories Inc., Elkhart, IN), washed 
again in PBS, and mounted in glycerol:PBS, pH 9.0. Micrographs were taken on 
a  Leitz Orthoplan  epifluorescence microscope and  recorded on Kodak Tri-X 
fill, ASA 400. 
Immunoblotting:  Cross-reactivity of antibodies was determined by 
immunoblots on  nitrocellulose paper  in a  Minimanifold block (Schleicber & 
Schuell, Inc., Keene, NH). Electrophoretically  pure cellular antigens calmodulin, 
parvalbumin, troponin C, 6s tubulin, and actin were blotted on 0.2 -tzm nitrocel- 
lulose paper (Schleicher & Schuell, Inc.) overnight at 4°C. Individual wells were 
then washed 10 times in PBS,  pH 7.4.  Nonspecific binding sites were blocked 
with  10 mg/ml BSA in PBS  for 2  h  at  22°C.  100/d of antibody-containing 
supernatant medium was then placed in each well and incubated (4°C overnight). 
Following 10x washing in PBS,  peroxidase-labeled goat anti-mouse immune- 
globulins (Cappel Laboratories, Inc., Cocbranville, PA) or rabbit anti-sheep IgG 
were  incubated at  room  temperature.  After  2  h  the  nitrocellulose sheet  was 
removed from the block and washed in PBS,  three changes, 20 min each. The 
entire nitrocellulose sheet was then placed in 100 ml of Tris-saline buffer, pH 7.4 
containing 25 mg/100 ml O-dionisodine and  100 #1 of 30% H202.  The reaction 
was stopped after 2-3 min by washing in water, and the developed blots were 
then air dried. 
Affinity Chromatography and Immunoprecipitation:  Su- 
pernatant medium from clone C-101-4 was precipitated with 40% Na2SO4, and 
the  pellet was  resolubilized in  PBS  and  applied  to  a  CaM-affinity  column 
prepared as in (l). Nonabsorbed protein was removed by washing with 0.1  M 
FIGURE  1  Strategy for in vitro immunization. In  vivo monoclonal production involves a long incubation period and  possible 
antigen degradation in situ  before recognition by the host immune system. In vitro immunization permits fl-lymphocyte binding 
of antigen with minimal degradation. Positive clones are screened by four criteria: EIA, immunofluorescence, affinity chromatog- 
raphy, and immunoprecipitation. 
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mM glycine  pH 2.7. Individual  fractions  of the flow-through  and the eluate  were 
then incubated  with 12~I-CaM overnight at 4°C. After 24 h,  100 #l of a 1:30 
dilution  of goat anti-mouse  antibody  was added. Following  incubation  for 1  h at 
room temperature, Staphylococcus  aureus was added for an additional hour. 
Samples  were then centrifuged  and washed twice in PBS, and radioactivity  was 
counted in a gamma counter. 
Cloning:  4-5 wks postfusion, positive wells were cloned by limiting 
dilution.  Each 1-ml  well  was diluted  to 10 ml in DME, 12% FCS. 100 #l was then 
added to each well  of  a 96-well  microtiter  plate and cells  were grown  to confluence 
before retesting. Those ceils positive for anticalmodulin  antibody production 
were then recloned at least two additional  times by limiting  dilution. 
RESULTS 
Polyclonal hybridoma cultures were  screened for  anti-CaM 
activity by four procedures: (a) enzyme immunosorbent  assay 
(EIA), (b) indirect immunofluorescence, (c)  antigen affinity 
chromatography, and (d)immunoprecipitation  125I-CaM. Lack 
of cross-reactivity of various clonal antibodies with other cel- 
lular proteins (parvalbumin, troponin C, actin, and 6S tubulin) 
was verified by immunoblot  procedures (Fig. 2). Initial screen- 
ing of polyclonal culture immunizations (C-I  through  C-5) 
demonstrated that 25~14% were positive. These positive cul- 
tures were then subcloned and rescreened for anti-CaM anti- 
body production (Table I).  In one spleen cell culture (C-6) 
immunized with 50 ng of CaM there were no detectable anti- 
CaM immunoglobulins. 10 different positive wells were cloned 
by  limiting dilution and  again  assayed  for  anticalmodulin 
(Table II). Of the  10 cloned cultures, 9 survived and prolifer- 
ated.  Six of the nine clones gave positive results in all of the 
screening procedures; clone C 101-10 died 5 d after subcloning. 
Three of the clones gave a positive reaction in EIA testing, but 
were negative in at least one of the other tests (C-101-2, C-101- 
6, C-101-19). Clone C-101-2 was unable to immunoprecipitate 
125I-CaM, using S.  aureus  or goat anti-mouse second Ab. C- 
101-6 was positive for EIA and negative for the three other 
tests.  These results are most likely reflective of differences in 
antibody titer or antibody affinity among the different clones. 
Hybridoma supernatant media,  Na2SO4  fraction or affinity- 
purified  antibodies were  used  to  stain  monolayers of 3T3 
FIGURE  2  Immunoblots of calmodulin monoclonal antibodies. Im- 
munoblots of calmodulin, troponin C, parvalbumin, 6S tubulin, and 
actin  with  supernatant  media  from  selected  clones.  Polyclonal, 
sheep anti-CaM and nonimmune mouse IgG were used as controls. 
TABLE  I 
Multiple In Vitro Immunizations 
Spleen  Immunization  % EIA positive first polyclonal 
number  dosage of CaM  screening 
C-1  1 mg  25% 
C-2  500 #g  30% 
C-3  100 #g  35% 
C-4  500 ng  40% 
C-5  200 ng  44% 
C-6  50 ng  No detectable response 
Six individual BALB/c mice spleens were separately immunized  with varying 
amounts of purified  bovine testes calmodulin  (I mg to S0 ng). Single  immu- 
nizations  in  vitro followed by 4-5  d  incubation  in  culture yielded  25-44% 
positive cultures  upon first  EIA  screening of polyclonal  cultures.  Single im- 
munizations in vitro produced  clones secreting predominately  IgM  (80%)  and 
some IgG's (20%) as tested with  anti-mouse  immunoglobulins,  anti-mouse 
IgM and anti-mouse IgG (Miles). 
fibroblasts by indirect immunofluorescence  (16). 
Calmodulin-affmity  chromatography  elution  of  a  40% 
Na2SO4-precipitated fraction of hybridoma supernatant media 
yielded specific calmodulin antibodies (Fig. 3). Only the peak 
of protein eluted with 200 mM glycine specifically immuno- 
precipitated '25I-CaM. The small number  of counts precipitated 
indicated low binding affinity of the antibody similar to the 
original goat anti-CaM antibodies reported by Dedman et al. 
(1).  Neither  goat  anti-mouse immunoglobulin, nonimmune 
mouse  immunoglobulins, rabbit serum,  nor affinity column 
flow-through were capable of immunoprecipitating I25I-CaM 
in  control  experiments.  When  monoclonal antibodies were 
preabsorbed with 1 mg/ml bovine or rat calmodulin, no pre- 
cipitation was  detected.  Preabsorption with  parvalbumin (1 
mg/ml) did not inhibit binding. 
To evaluate whether the individual clones would recognize 
different aspects  of CaM,  antibodies from individual clones 
were used to stain cultured Swiss 3T3 cells by immunofluores- 
cence.  Purified  media  from  clone  C-101-1  resulted  in  the 
localization of CaM  in the mitotic spindle (Fig. 4A~, A2) as 
previously demonstrated by Welsh et al. (17) and Andersen et 
al. (18) using goat and rabbit polyclonal anti-CaM. Clone C- 
101-4 antibody decorated stress  fibers and centrioles, respec- 
tively, in interphase 3T3  cells (Fig.  4B,  and B2). Antibody 
from clone C-101-15 localized CaM  bound to  mitochondria 
and resulted in some faint staining of stress  fibers (Fig. 4 C~ 
and C2). No cellular structures other than those shown were 
stained with this set of monoclonal antibodies. Neither fetal 
bovine serum,  rabbit serum, nonimmune mouse serum,  nor 
supernatant  medium  from  a  nonimmunized mouse  spleen 
hybridoma specifically stained cells or was capable of binding 
to isolated calmodulin by the three other test criteria. Preab- 
sorption of monoclonal antibodies with excess  of calmodulin 
(1  mg/ml) eliminated staining while antibodies preabsorbed 
with parvalbumin (1  mg/ml) had  little or  no effect  on the 
specificity of the  antibody. These  immunofluorescence data 
suggest  the  unique specificity of monoclonal as  opposed  to 
polyclonal antibodies for protein localization. CaM has previ- 
ously been localized to stress  fibers with goat antibodies only 
after prolonged (6-h) incubation  periods with primary antibody 
(17).  Pardue and co-workers (19) utilizing rhodamine-labeled 
CaM demonstrated that CaM acceptor sites (CAPs) are asso- 
ciated with mitochondria while conventional polyclonal anti- 
calmodulin antibodies were unable to detect these sites unless 
permeabilized cells were  first  pre-incubated with exogenous 
calmodulin. The lack of staining of stress fibers and mitochon- 
dria by polyclonal anti-CaM may lie in the inability of these 
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when bound  to various cellular structures may be totally or 
partially hidden by its conformational arrangement with the 
associated acceptor protein. This possibility is supported by the 
fact that most polyclonal CaM antibodies will not immunopre- 
cipitate by intramolecular cross-linking,  suggesting  a restricted 
number of antigenic sites (l). In fact, Van Eldik and Watterson 
(3) have shown that multiple rabbit antisera produced against 
performic acid-oxidized calmodulin recognize a  unique  car- 
boxy-terminal domain. Thus, the predominant antigenic sites 
normally seen in free calmodulin would not be available for 
antibody binding. 
DISCUSSION 
In vitro immunization of spleen cell cultures offers an oppor- 
tunity to produce antibodies against highly conserved proteins 
that are poorly antigenic by in vivo standards. This procedure 
allows for the stimulation of fl-lymphocytes with nanogram 
quantities of antigen in their native state.  In our laboratory, 
tubulin (200 ng), actin (200 ng), and calmodulin (200 ng to l 
ng) have proven sufficiently antigenic to elicit specific antibody 
response in vitro. Luben and Mohler (9) have immunized in 
vitro with  50  ng of osteoclast activating factor (OAF),  with 
similar positive results. More recently, picomole amounts of rat 
hypothalamic growth hormone-releasing factor (rGRF) have 
been used successfully  for in vitro immunization and produc- 
tion of monoclonal antibodies (10). Thus, nanogram quantities 
of soluble protein antigens appear to be sufficient to stimulate 
fl-lymphocytes to produce specific antibodies that can be de- 
tected  within  2-4 wk after fusion.  Mouse  monoclonal anti- 
bodies produced by in vitro immunization with bovine cal- 
modulin were also cross-reactive with mouse and rat calmod- 
ulin.  The in vivo regulation of antigen recognition and proc- 
essing through immunological tolerance and suppression mech- 
TABLE  II 
Immunological Evaluation of Monoclonal Antibody  from Several Clones 
Calmodulin af-  Immunopre- 
Cell structures stained by  finity:J: elution  cipitation 
Clone no.  EIA* O.D.  immunofluorescence  peak O.D.280  cpm§ 
C-101-1  0.38  Mitotic spindle  0.12  200 
C-101-2  0.41  Mitotic spindle  0.14  0 
C-101-4  0.51  Centrioles and stress fibers  0.10  250 
C-101-6  0.42  None  0.00  0 
C-101-8  0.39  Mitotic spindle  0.11  211 
C-101-10  .... 
C-101-15  0.54  Mitochondria and stress fibers  0.16  201 
O101-18  0.48  Centrioles and stress fibers  0.13  190 
C-101-19  0.40  None  0.09  182 
C-101-27  0.40  Mitotic spindle  0.10  159 
Fetal  bovine serum  0  None  0  0 
Rabbit serum  0  None  0  0 
Nonimmune mouse serum  0  None  0  0 
Media from nonimmune mouse spleen hybridoma  0  None  0  0 
Monoclonal Ab to CaM absorbed with 
(1)  CaM  0  None  0  0 
(2)  Parvalbumin  0.38  Mitotic spindle  0.12  205 
*  EIA background subtracted from above readings. 
:[: Affinity column O.D.280 maximum reading for each clone. 
§ Total counts of 1251=CaM =  10,000; above counts represent total counts minus background. 
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FIGURE  3  Determination  of  monoclonal 
anti-CaM  activity via affinity  chromatogra- 
phy and immunoprecipitation. Supernatant 
media from various clones were sodium sul- 
fate precipitated and passed  over a Sepha- 
rose  4B-CnBr  calmodulin  column.  Peak  1 
contained  no detectable antibody capable 
of  immunoprecipitating  l~sl-CaM.  Peak  2 
was eluted with pH 2.7, 200 mM glycine and 
demonstrated calmodulin-binding specific- 
ity of low affinity.  Unlabeled calmodulin (1 
mg/ml) completely inhibited binding while 
1 mg/ml parvalbumin did not. Second anti- 
body alone did not immunoprecipitate 12Sl- 
CaM. FIGURE  4  Panel  AI  and  A2  demonstrate typical  half-spindle  staining  using  monoclonal anti-calmodulin  (clone  C-101-1);  this 
antibody has a high affinity for CaM associated with  the asters and mitotic spindle. Anticalmodulin  produced by clones C-101-4 
and  C-101-18  preferentially localized CaM  in  association with  centrioles and  stress  fibers  (B1  and  B2). Clone C-101-15 yielded 
antibody which  recognized CaM  bound  to  mitochondria and  some stress  fibers  but  not to centrioles or spindles  ( G  and  C2). 
Neither normal mouse immunoglobulins, rabbit serum, nor monoclonal antibody absorbed with 1 mg/ml calmodulin stained cells 
by indirect immunofluorescence. 
anisms  appear  to  be  altered  under  in  vitro  conditions  (12). 
Murine  autoreactive  antibodies  are  the  major  products  of 
polyclonal B-cell activation  of mouse  spleen  cells  (20),  thus 
minimizing the potential autoantibodies to mouse calmodulin. 
Autoreactive  murine  monoclonal  antibodies  to  angiotensin- 
converting enzyme have recently been reported after conven- 
tional in vivo immunization (Auerbach, R., L. Alby, J. Grieves, 
J. Joseph, C. Lindgren, L. W. Morrisey, Y. A. Sidky, M. Tu, 
and S. L. Watt, manuscript submitted for publication). 
80%  of the  hybridomas produced in the present  study se- 
creted IgM (as opposed to IgG's) when single immunizations 
were used. When spleen cell cultures were exposed to secondary 
and tertiary in vitro immunizations during extended immuni- 
zation periods, the ratio was altered to 50% IgM to 50% IgG's. 
The high percentage of IgM producers most likely represents 
an increased frequency of  fusion of immature plasma cells with 
myeloma cells to form the hybridoma. The above data repre- 
sent the generation of individual hybridoma clones that pro- 
duce monoclonal antibodies which localize calmodulin in as- 
sociation with other intracellular proteins. These studies suggest 
that  intracellular  calmodulin  may differentially  expose  anti- 
genic sites  or limited regions of one complex site,  depending 
upon the cellular binding protein with which it is interacting. 
Thus,  unlike  polyclonal  antibodies,  monoclonal  antibodies 
make  it  possible  to  study specific interactions  of CaM  with 
other  cellular  macromolecules.  This  techique  should  aid  in 
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various cellular functions. 
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